drugset / Trial / NCT01213563

Management of Type 2 Diabetes After Gastric Bypass Surgery

NCT01213563 ↗

Terminated 50 enrolled Imperial College London
RandomizedParallel-groupSingle-blindSupportive care

Summary

Gastric bypass surgery has been proposed as an effective treatment strategy for type 2 diabetes mellitus (T2DM), but thus far algorithms for the management of T2DM immediately after surgery have not been established. The investigators designed an algorithm to achieve good glycaemic control in patients with insulin-requiring T2DM upon discharge after gastric bypass surgery, and evaluated this algorithm for feasibility, efficacy, and safety.

Timeline

Start
2009-01
Primary completion
2010-09
Completion
2010-09

Outcome

Outcome not reported

Stopped: “Data were published that superseded this study.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Actrapid insulin Unknown — —
Comparator Glucose Unknown — —